NOVORAPID FLEXPEN

Description

NOVORAPID FLEXPEN 5X3 ML READY INJ.

NovoRapid FlexPen is a brand name for the medication insulin aspart, which is a fast-acting insulin analog used to treat diabetes. It is produced by the company Novo Nordisk.

NovoRapid FlexPen is a pre-filled pen that contains insulin aspart in a solution for injection. It is designed for subcutaneous injection, typically taken just before a meal, to help regulate blood sugar levels after eating.

Insulin aspart works by mimicking the action of natural insulin, which helps to transport glucose from the bloodstream into cells for energy. NovoRapid FlexPen can help to regulate blood sugar levels after meals and reduce the risk of complications associated with uncontrolled blood sugar, such as nerve damage, kidney damage, and eye damage.

Common side effects of NovoRapid FlexPen may include low blood sugar (hypoglycemia), injection site reactions, weight gain, and fluid retention. More serious side effects are rare but can include allergic reactions and insulin resistance.

It should be noted that NovoRapid FlexPen can interact with other medications, and it is important to inform a doctor or healthcare provider of all medications being taken before starting treatment with NovoRapid FlexPen. NovoRapid FlexPen is available only by prescription and should only be used under the guidance of a healthcare provider.